Try our Advanced Search for more refined results
Life Sciences - January, 2010
182 articles
- Cos. Pay Big To Settle Patent Fights With Rivals
- Merck Drug Liability MDL To Go To Trial: Judge
- Monaghan Medical To Stop Sales Of Disputed Inhaler
- IMS Health Settles Shareholder Suits Over Merger
- USPTO To Update Patent Term System After Ruling
- Aventis Wins Dismissal Of $3M Fraudulent Transfer Suit
- Levaquin Plaintiffs Seek To Pry Docs From J&J's Hands
- Orrick IP Litigator Joins Sidley Austin In San Francisco
- Generics Makers Challenge AstraZeneca In Crestor MDL
- Patent Nixed From Hologic-Ethicon Breast Biopsy Spat
- Par, Fleming Drop Spat Over Nasal Spray Patent
- NY Claims Stand In AWP Drug MDL
- House Panel Advances Inquiry Into Health Bill Deal
- Greenberg Snags Wollmuth Maher Securities Partner
- Canadian Securities Class Actions Take Slight Dip
- FTC OKs $650M Danaher-MDS Deal With Conditions
- Subclasses Dismissed In Dentsply Negligence Case
- Flonase Antitrust Suit Withstands GSK Dismissal Bid
- The Outcome Of Overly Broad Restrictive Covenants
- Bavarian, BioMedica Call Vaccine Patent Truce
- Sex Bias Plaintiffs' Bid To Sanction Novartis Nixed
- Novartis Reaches $185M Deal Over Off-Label Claims
- Teva Triumphs Over Merck In Temodar Patent Spat
- Defect Sparks Massive Nipro Needle Recall
- Ex-Assistant Manager Hits CVS With Overtime Action
- J&J, Swiss Co. End OneTouch Counterfeit Feud
- Bausch & Lomb Appeals 'ReNu' Duty To Defend Loss
- Written Description: Not Co-Extensive With Enablement
- Fed. Circ. Finds Boehringer's Mirapex Patent Valid
- PerkinElmer Patent Suit Dropped Days After It Began
- J&J Unit Wins Bid To Nix Tylenol Product Liability Suit
- Cephalon Slaps Sandoz Over Generic Narcolepsy Drug
- Fed. Circ. Affirms Abbott Losses Over Test Strip Patents
- Pfizer Wants Wyeth Merger Case Thrown Out For Good
- Diprivan Supplier Beefs Up AstraZeneca Contract Suit
- Trumpf Fights To Nix Duties On Surgical Lamps
- BioScrip Snags Critical Homecare For $343M
- FDCA And Liability For State Failure-To-Warn Claims
- Medtronic Puts $350M Down For Invatec
- Ala. AG Loses Bid To Revive $275M AWP Cases
- Fed. Circ. Deals Blow To Takeda In Prevacid Battle
- Nipro Issues Recall Of Insulin Syringes Sold In US
- Judge Advises To Keep Expert In Dentsply Case
- Flonase Indirect Buyers Survive Standing Challenge
- Sequenom To End Shareholder Suits With $45M Deal
- Consumers Push For Class Status In Digitek MDL
- Court Limits Atty Contact With MDs In Ortho Evra MDL
- Abbott Offers EU Antitrust Remedies On Solvay Deal
- J&J Stent Patents Found Invalid In Boston Sci Suit
- Abbott Stops Marketing Weight Loss Drug In Europe
- As Trial Nears, Kaiser Flays Pfizer Neurontin Studies
- German Courts Weigh In On Edwards' Patent Fight
- Health Cos. Bear Brunt Of State AGs' Antitrust Focus
- Martek To Buy Supplement Maker Amerifit For $200M
- Huge Antitrust Fines Reflect Regulators' Bold Stance
- Pfizer Settles Zoloft Preemption Case
- FDA Taps Acting Director To Lead Devices Unit
- Class Decertification Stands In Pa. Neurontin Suit
- Abbott's 'New Theories' In AWP Case Draw US' Ire
- Katten Lures Sonnenschein White Collar, Health Attys
- Top Antitrust Deals Of '09 Have Enforcement Tie
- New DOJ Position To Oversee Discovery Initiatives
- Boston Scientific Stent Patent Suit Moved To NJ
- Tech, Energy Took Biggest Antitrust Hits Last Year
- Cordis Sues Boston Scientific Over Stent Patents
- Medical Cos. Get OK For Long Brief In Gene Patent Spat
- Tyco Settles Syringe Disposer Antitrust Suit For $33M
- SLU Hospital Escapes Guidant Defibrillator MDL
- Determining Obviousness — Graham Plus KSR?
- Molina Healthcare Buys Unisys Unit For $135M
- Ala. Top Court Reverses Class Cert. In Duract Case
- Pfizer Slaps Teva With Suit Over Zyvox ANDA
- Judge OKs Howmedica's Appeal Of Invalidity Ruling
- Ethicon Must Turn In Evidence In ObTape MDL
- Genzyme, Daiichi Try To Halt Impax's Generic Welchol
- Obama Wants To Limit Biologic Protection In Health Bill
- Abbott, Others Marketed Stents Off-Label: Suit
- J&J Unit Widens Recall Over Contamination Concerns
- Judge Refuses To Nix Bristol-Myers' Sustiva Case
- DOJ Slaps J&J Over Millions In Kickbacks To Omnicare
- Review Of 2009 Antitrust Case Law
- Importing Drugs, Medical Devices To US From China
- Don't Nix Gene Patents, BPLA Tells Court
- KV To Settle Claims Against Citigroup In ARS MDL
- Shareholders Fight Amgen's Stay Bid
- Judge Slams FDA Over Detained Electronic Smokes
- Apotex Wants Abbott's Meridia Patent Suit Out Of Del.
- Kirkland & Ellis Patent Pro Joins Quinn Emanuel
- Germany: Forum Of Choice For Patent Litigation?
- Luna Wins Ch. 11 OK After Settlement With Hansen
- Mannatech Resolves Supplement Patent Case
- Law360 IP Editorial Advisory Board
- FTC Tells Congress To Scrap Pay-For-Delay
- US Fights DeCode Asset Sale Due To Security Risks
- Norvir Antitrust Cases Survive Abbott's Bid To Dismiss
- Cook Stent Patent Suit Stayed For Re-Exam
- Law360 Securities Editorial Advisory Board
- Law360 Corporate Finance Editorial Advisory Board
- Law360 Bankruptcy Editorial Advisory Board
- IP Cases Of The Decade
- Judge Picks Merck's Discovery Plan In NuvaRing MDL
- Pharma Industry Under Antitrust Scrutiny
- NY Stops Drug Flushing At 5 Health Care Facilities
- FDA Scolds Lilly, Bayer, Others Over Drug Ads
- Merck Discovery Bid Mooted In NuvaRing MDL
- Sonnenschein Nabs Biotech Expert From Dickstein
- EC To Monitor Pharma Patent Settlements
- Product Liability Cases Of The Decade
- Quidel Picks Up Diagnostic Hybrids For $130M
- Novo Nordisk, Sanofi Cap Feud Over Insulin Pen
- High Court Rebuffs Boston Scientific Section 271(f) Suit
- Synthes, Howmedica End Bone Device Patent Suits
- Consumer Groups, AAI Push Pay-For-Delay Ban
- Supreme Court Won't Take On Omnicef Patent Case
- Former Indevus VP Agrees To Insider Trading Deal
- Pension Fund Sues To Block Novartis, Alcon Deal
- License Deal Ends IP Spat Between Caliper, BD
- Q&A With Kenyon & Kenyon's James Galbraith
- FDA Halts Sybaritic Sales Of Unapproved Devices
- Pharmacies Hone Claims In Pfizer-Wyeth Merger Suit
- Aetna, Guardian Ousted From Neurontin Off-Label MDL
- Apotex Seeks Stay In Plavix Suit Pending USPTO Ruling
- 5th Circ. Rejects Generic Preemption Argument
- Inverness Sues Rival Over Pregnancy Test Patent
- 9th Circ. Denies Rehearing In CTI Contract Suit
- Lawson To Snap Up Healthvision For $160M
- Arnold & Porter Snatches Milbank Patent Team
- Cynosure Wins Defense Coverage For Blast Fax Action
- Synthon Claims Sepracor Misled USPTO On Xyzal
- Biomet Settles Trade Secrets Suit With Ex-Distributor
- Shareholders Appeal NeuroMetrix Fraud Dismissal
- Dentsply Class Action Over Cavitron Is Back On Track
- Wyeth Scores In Patent Term Adjustment Spat With PTO
- Del. Judge Tosses 2 Seroquel Suits
- AstraZeneca, Teva Settle Heartburn Drug Patent Suits
- Abbott Coughs Up $23M To Settle Patent Fraud Claims
- Stryker To Exit Acacia Unit Medical Imaging Patent Suit
- Interpreting Oral Arguments In Ariad V. Eli Lilly
- FDA Warns Against Bystolic For Heart Patients
- EU Launches Antitrust Probe Over Lundbeck Drug
- FDA To Look At Risks Of J&J, Amgen Anemia Drugs
- GSK Liability Suit Remanded To Ill. State Court
- KV Action Over Metoprolol Preempted: Judge
- 8th Circ. Ships 3 Prempro Suits Back To State Court
- Cephalon Deals Went Beyond Provigil: Direct Buyers
- 7th Circ. Hands U. Of Wis. Victory In Licensing Fight
- Orrick Lands Hughes Hubbard Antitrust, Health Atty
- FDA To Study Drug Safety For Pregnant Women, Fetuses
- Cephalon Sues Watson Over Generic Nuvigil
- Monsanto, Pfizer PCB Suits Sent Back To State Court
- Novartis, Roxane Drop Most Famvir Patent Claims
- Allergan Can Demand Jury In Sandoz IP Fight: Judge
- A Closer Look At Supreme Court Arguments In Bilski
- 8th Circ. Denies W. Va. Baycol Plaintiffs Bid To Refile
- Fed. Circ. Revives Philips Defibrillator Patent Suit
- Sterne Kessler Nabs 4 IP Litigators From Blank Rome
- Novartis Snaps Up Corthera For $120M
- Pa. Appeals Court Upholds $1.5M Provera Verdict
- Medicines Co. Hits Teva With New Angiomax Suits
- Gene Patents Don't Violate Constitution: USPTO
- Spectranetics To Pay $5M Over Unapproved Lasers
- Centocor Seeks Continuing Damages Over Humira
- SOX Gives Whistleblowers De Novo Review: 4th Circ.
- Generics Makers Infringe Lilly's Strattera Patent: Judge
- Paratek Sues USPTO Over Drug Patent Term
- Lexington Need Not Cover B&L's ReNu Claims: Judge
- Competition Firms Of The Year
- Novartis Snaps Up Nestle's Alcon Share For $28.1B
- Q&A With LeClairRyan's Michael Drzal
- Product Liability Legislation To Watch In 2010
- Health Cases To Watch In 2010
- Financial Services Cases To Watch In 2010
- Product Liability Cases To Watch In 2010
- IP Cases To Watch In 2010
- Competition Cases To Watch In 2010
- Old Litigation Patterns Likely To Resurface In 2010
- Product Liability Plaintiffs Firms Of The Year
- IP Firms Of The Year
- Securities Defense Firms Of The Year
- Product Liability Defense Firms Of The Year
- Plaintiffs Securities Firms Of The Year
- Product Liability Defense Lawyers' Wish List For 2010